stifffenhopkins-blog

[stifffenhopkins-blog]

Global Ventilator Market is expected to reach USD 1382.2 Million by 2026 from USD 628.5 Million in 2016 at a CAGR of 8.2% (Detailed analysis of the market CAGR is provided in the report). Ventilators are mainly used in intensive care medicine, home care, and emergency medicine and in the case of anesthesia. Modern ventilators are computerized machines, in which patients can be ventilated with a simple hand-operated bag valve mask.

[stifffenhopkins-blog]

Medical Ceramics Market is expected to reach USD 24.98 Billion by 2026 from USD 12.94 Billion in 2016 at a CAGR of 6.8% (Detailed analysis of the market CAGR is provided in the report). Medical ceramics are extensively used in surgical implants, prosthetics and a number of medical tools and devices.

[stifffenhopkins-blog]

Global DNA sequencing market was valued US$ 7.9 Bn in 2017 and is expected to reach US$ 29.6 Bn by 2026, at a CAGR of 17.95 % during a forecast period.

[stifffenhopkins-blog]

Global Pharmaceutical Packaging Equipment Market is expected to reach USD 9.43 Billion by 2024 from USD 5.56 Billion in 2016 at CAGR of 6.83% (Detailed analysis of the market CAGR is provided in the report).

[stifffenhopkins-blog]

Breast Cancer Liquid Biopsy Market is expected to reach US$ XX Mn by 2026 at a CAGR of XX% during the forecast period. A breast cancer liquid biopsy is a simple and non-invasive alternative to surgical biopsies which enables doctors to discover a range of information about a tumor through a simple blood sample. Traces of cancer's DNA in the blood can give clues about the treatments that are most likely to work for that patient. In addition, breast cancer liquid biopsy may improve therapies and achieve better clinical outcomes in patients. Breast Cancer Liquid Biopsy is highly fragmented due to technological advancement and innovations in medical treatment.

[stifffenhopkins-blog]

Global Homeopathy Products Market

[stifffenhopkins-blog]

Global Antihypertensive Market is estimated to surpass XX USD Billion mark in 2017 at a Compound Annual Growth Rate (CAGR) of XX% during the forecast period 2018-2024 globally. Hypertension is a chronic condition associated with abnormal blood pressure elevation in both diastolic and systolic. Hypertension is highly associated with premature death worldwide and is a key concern in public health in both developing and developed countries. The anti-hypertension drugs are used for leveling or reducing blood pressure. In 2016, the prevalence of hypertension was estimated to be more than 38% of adults worldwide, which has increased by 5% globally between 2000 and 2015. It is also observed that the prevalence rate has decreased by 2.4% in developed countries, but has increased in low as well as middle-income countries because of obstacles and limited resources in healthcare delivery. There is also a need for stringent measures to prevent, treat and control hypertension along with improving awareness for boosting the global anti-hypertensive market.

[stifffenhopkins-blog]

Blood Collection Vacuum Devices Market is expected to reach USD XX Billion in 2024 from USD XX Billion in 2016, with a CAGR XX%. Vacuum blood collection devices are used to collect & store the blood sample. These devices are based on vacuum technology consisting double-pointed needle, adaptor which develops vacuum to withdraw blood. This device avoids needle stick injury by removing needles from human contact & also avoids the potential aero soling. The vacuum blood collection devices are easy to operate and technically better than other Blood Collection Vacuum Devices Market. The World Health Organizations estimates the global diabetes is expected to grow to 438 million by 2030 from 285 million in 2015. India has almost 50 million diabetic patients which are expected to reach 87 million by 2030.

[stifffenhopkins-blog]

The global epigenomic market was valued US$ 5.28 Bn in 2017 and is expected to reach US$ 16.3 Bn by 2026, at a CAGR of 15.13 % during a forecast period. Growing applications in personalized medicine & targeted therapy in oncology and the use of epigenetics in non-oncology applications is a growth opportunity for the epigenetics market. Increase in the prevalence of cancer & other chronic diseases, a rise in the aging population, and a decrease in the sequencing costs & time is driving the growth of the market. Growth in funding for research & development, need for better cancer therapies, development in personalized medicine, and the increasing importance of epigenetic technology is also boosting the market growth. The high cost of instruments is limiting the growth of the market. Some challenges of the market are concerns regarding the quality of antibodies, and a lack of trained professionals.

[stifffenhopkins-blog]

Global Diagnostic Speciality Enzymes Market was valued US$686.2 Mn in 2017 and expected to reach US$1401.7 Mn by 2026, at a CAGR of 7.5% during forecast period. Global diagnostic speciality enzymes market is segmented into type, source, application, and region. On the basis of type, market is segmented into acylases, hydratases, humulin, oxidase, lyases, restriction enzymes, ligases, polymerases, lipases, amylases, proteases, dehydrogenases, glucouronidse, others. Based on source, market is divided into microorganisms, plants, and animals. According to application, market is divided into Pharmaceutical, Biotechnology R&D, and Diagnostic. Geographically market is spread into North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa.

[stifffenhopkins-blog]

Global Healthcare Middleware Market was valued US$ 1.79 Bn in 2017 and is estimated to reach US$ 4.25 Bn by 2026 at a CAGR of more than 11.41% during a forecast period. Global Healthcare Middleware Market is segmented by Type, by Application, by Deployments Model, by End User, and by Region. Healthcare Middleware Market by Type segment is classified into Communication, Platform, and Integration. By Application segment classified into Clinical, Financial and Operational & Administrative. By Deployments Model segment is classified into On-premise, Cloud, and Hybrid. By End, User segment is classified into Healthcare Payers, Healthcare Providers, Life Science Organizations, and Clinical Laboratories. Geographically split into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.

[stifffenhopkins-blog]

BRICS Diabetes Drugs Market is expected to reach USD 61.59 billion by 2026, from 12.7 billion in 2016 at a CAGR of 17.5%.(Detailed analysis of the market CAGR is provided in the report)Diabetes is a chronic disease characterized by high blood sugar level, the main cause of diabetes is improper functioning of the pancreas which secretes insulin. The diabetes Drug market is completely based on the drug used to lower glucose level in the blood, with the help of oral hypoglycemic agents or oral antihyperglycemic agents to ensure treatment of diabetes Selection of different types of diabetes drug completely depends upon • Nature of the Diabetes • Age • Situation of the Person

[stifffenhopkins-blog]

Kidney/Renal Function Test Market is expected to reach USD 1083.4 Million by 2026 from USD 582.6 Million in 2016 at a CAGR of 6.4% (Detailed analysis of the market CAGR is provided in the report). Kidneys play several crucial roles in maintaining health. One of their most important roles is to filter waste materials from the blood and drive out them from the body as urine. The kidneys also help to control the water levels and different essential minerals in the body. In addition, they are vital to the production of vitamin D, red blood cells, hormones that regulate blood pressure. In case a kidney is not working properly, there are simple blood and urine tests that can identify kidney function problems.

[stifffenhopkins-blog]

Asia Pacific Active Pharmaceutical Ingredients Market is expected to reach USD 57.5 Billion by 2026 from USD 29.2 Billion in 2016 at a CAGR of 7.0% (Detailed analysis of the market CAGR is provided in the report). An active ingredient or AI is that component of the pharmaceutical drug that is biologically active and is also synonymously known as an active pharmaceutical ingredient (API) or bulk active. Amount of API depends on the manufacturers and differs from one brand to another where at times more than one API chemical compound is used within drugs. In distinction with the active components, the inactive elements are called as excipients in pharmaceutical backgrounds. Excipients are chemically inactive constituents that do not react directly with API that in turn preserves the precise drug composition. The main excipient serving as an intermediate for transmission of the active ingredient is known as the vehicle. Petroleum jelly and mineral oil are some of the most frequently used vehicles that are required for drug composition.

[stifffenhopkins-blog]

Global Therapeutic Respiratory Devices Market is expected to grow at CAGR of around 9.6% and will exceed over 17 billion USD by 2024. Major drivers of Global Therapeutic Respiratory Devices Market are rising aging population, increasing the incidence of respiratory diseases like asthma and growing levels of pollution day by day. Urbanization, an increase in the number of factories with harmful chemical disposure to air causes an increase in population that will increase in respiratory problems among people that will give demand for therapeutic respiratory devices. Rapid development in the Asia Pacific region and increasing demand for respiratory devices fuel the Global Therapeutic Respiratory Devices Market.